← FDA DRUG APPROVALS

FDA ANDA · ANDA075185

DICLOFENAC SODIUM DELAYED RELEASE

diclofenac sodium

Sponsor: CARLSBAD

APPLICATION
ANDA075185
TYPE
ANDA
ORIGINAL APPROVAL
1998-11-13
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
TABLET, DELAYED RELEASE
MARKETING STATUS
Prescription

Products

DICLOFENAC SODIUMPrescription
DICLOFENAC SODIUM 50MG · TABLET, DELAYED RELEASE · ORAL
DICLOFENAC SODIUMPrescription
DICLOFENAC SODIUM 75MG · TABLET, DELAYED RELEASE · ORAL
DICLOFENAC SODIUMPrescription
DICLOFENAC SODIUM 25MG · TABLET, DELAYED RELEASE · ORAL

Approval history

2024-11-21Labeling · Supplement 20 · standardAP
2021-04-29Labeling · Supplement 16 · standardAP
2021-04-29Labeling · Supplement 15 · standardAP
2021-04-20Labeling · Supplement 13 · standardAP
2016-05-09Labeling · Supplement 12 · standardAP
2015-08-24Labeling · Supplement 11AP
2010-02-18Labeling · Supplement 8AP
2006-02-23Labeling · Supplement 5AP
2003-11-19Labeling · Supplement 3AP
1998-11-13Original — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →